Volume 12, Issue 4 (Autumn 2023)
aumj 2023, 12(4): 428-437 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zarehdar R, Hassanpourezatti M. Evaluation of malondialdehyde and Tumor Necrosis Factor-alpha level in the brain of carbamazepine and vitamin B-6 combined treatment groups in the infant rat model of maximum electroshock seizure. aumj 2023; 12 (4) :428-437
URL: http://aums.abzums.ac.ir/article-1-1601-en.html
URL: http://aums.abzums.ac.ir/article-1-1601-en.html
1- Master of Sciences, Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran.
2- Associate professor, Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran.
2- Associate professor, Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran.
Abstract: (733 Views)
Introduction: Despite the development of new drugs over the past 20 years, the proportion of drug-resistant epilepsy has not changed. In this study, the effect of vitamin B6 and carbamazepine cotreatment was investigated on the duration of the tonic response, the malondialdehyde (MDA) and tumor necrosis factor alpha (TNF-α) levels in the brain of neonate rats in the maximal electroshock (MES) model.
Methods: Seventy neonatal Wistar rats were divided into seven groups: (1) control, (2) saline and MES, (3) carbamazepine (40 mg/kg), (4 and 5) vitamin B-6 (300 and 600 mg/kg), and (6 and 7) vitamin B-6 + carbamazepine (300 + 40 mg/kg) and (600 + 40 mg/kg). All drugs were injected intraperitoneally 1 hour before applying MES. The duration of hind leg extension (HLE), and the level MDA and TNF-α in brain homogenate of rats were measured.
Results: The treatments did not affect the number of deaths of rats. Administration of carbamazepine (40mg/kg, i.p.) and vitamin B6 (300 mg/kg, i.p.) significantly (p <0.01) reduced the HLE duration. Vitamin B-6 (600 mg/kg) only enhanced the reducing effect of carbamazepine on the duration of HLE compared to the carbamazepine alone group. Treatment with vitamin B-6 and carbamazepine alone reduced the level of MDA and TNF-α in the brain of convulsive rats, but their combined administration did not have a synergistic effect on the suppression of these factors.
Conclusion: The mechanism underlying the enhancement of the anticonvulsant response of carbamazepine administration with vitamin B-6 is independent of the modulation of MDA and TNF-a in the brain.
Methods: Seventy neonatal Wistar rats were divided into seven groups: (1) control, (2) saline and MES, (3) carbamazepine (40 mg/kg), (4 and 5) vitamin B-6 (300 and 600 mg/kg), and (6 and 7) vitamin B-6 + carbamazepine (300 + 40 mg/kg) and (600 + 40 mg/kg). All drugs were injected intraperitoneally 1 hour before applying MES. The duration of hind leg extension (HLE), and the level MDA and TNF-α in brain homogenate of rats were measured.
Results: The treatments did not affect the number of deaths of rats. Administration of carbamazepine (40mg/kg, i.p.) and vitamin B6 (300 mg/kg, i.p.) significantly (p <0.01) reduced the HLE duration. Vitamin B-6 (600 mg/kg) only enhanced the reducing effect of carbamazepine on the duration of HLE compared to the carbamazepine alone group. Treatment with vitamin B-6 and carbamazepine alone reduced the level of MDA and TNF-α in the brain of convulsive rats, but their combined administration did not have a synergistic effect on the suppression of these factors.
Conclusion: The mechanism underlying the enhancement of the anticonvulsant response of carbamazepine administration with vitamin B-6 is independent of the modulation of MDA and TNF-a in the brain.
Keywords: Seizures, Vitamin B6, infant, carbamazepine, Tumor Necrosis Factor-alpha, malondialdehyde.
Type of Study: Research |
Subject:
Special
Received: 2022/08/14 | Accepted: 2022/12/05 | Published: 2023/12/01
Received: 2022/08/14 | Accepted: 2022/12/05 | Published: 2023/12/01
References
1. Nabavi SS, Partovi P. Brain Ultrasonography Findings in Neonatal Seizure; a Cross-sectional Study. Emerg (Tehran). 2017;5(1):e41.
2. Aaberg K. M, Gunnes N, Bakken I. J, Lund Søraas C, Berntsen A, Magnus P, et al. Incidence and Prevalence of Childhood Epilepsy: A Nationwide Cohort Study. Pediatrics 2017; 139(5): e20163908. doi:10.1542/peds.2016-3908 [DOI:10.1542/peds.2016-3908]
3. Plouin P, Kaminska A. Neonatal seizures. Handb Clin Neurol. 2013;111:467-76. doi: 10.1016/B978-0-444-52891-9.00051-8. [DOI:10.1016/B978-0-444-52891-9.00051-8]
4. Numis AL, Foster-Barber A, Deng X, Rogers EE, Barkovich AJ, Ferriero DM, Glass HC. Early changes in pro-inflammatory cytokine levels in neonates with encephalopathy are associated with remote epilepsy. Pediatr Res. 2019;86(5):616-621. doi: 10.1038/s41390-019-0473-x. [DOI:10.1038/s41390-019-0473-x]
5. Ambrogini P, Torquato P, Bartolini D, Albertini MC, Lattanzi D, Di Palma M, Marinelli R, Betti M, Minelli A, Cuppini R, Galli F. Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1098-1112. doi: 10.1016/j.bbadis.2019.01.026. [DOI:10.1016/j.bbadis.2019.01.026]
6. Silenieks LB, Carroll NK, Van Niekerk A, Van Niekerk E, Taylor C, Upton N, Higgins GA. Evaluation of Selective 5-HT2C Agonists in Acute Seizure Models. ACS Chem Neurosci 2019; 10(7): 3284‐3295. doi:10.1021/acschemneuro.8b00739 [DOI:10.1021/acschemneuro.8b00739]
7. Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology. 2020; 168: 107966. doi: 10. 1016/ j.neuropharm. 2020. 107966. [DOI:10.1016/j.neuropharm.2020.107966]
8. Sands TT, Balestri M, Bellini G, Mulkey SB, Danhaive O, Bakken EH, Taglialatela M, Oldham MS, Vigevano F, Holmes GL, Cilio MR. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. Epilepsia. 2016; 57(12):2019-2030. doi: 10.1111/epi.13596. [DOI:10.1111/epi.13596]
9. Sobaniec W, Solowiej E, Kulak W, Bockowski L, Smigielska-Kuzia J, Artemowicz B. Evaluation of the influence of antiepileptic therapy on antioxidant enzyme activity and lipid peroxidation in erythrocytes of children with epilepsy. Child Neurol 2006: 21: 558-62. doi: 10.1177/08830738060210070501. [DOI:10.1177/08830738060210070501]
10. Tunali S. The effects of vitamin B6 on lens antioxidant system in valproic acid-administered rats. Hum Exp Toxicol. 2014;33(6):623-8. doi: 10.1177/0960327113506233. [DOI:10.1177/0960327113506233]
11. Reid ES, Williams H, Stabej Ple Q, James C, Ocaka L, Bacchelli C, Footitt EJ, Boyd S, Cleary MA, Mills PB, Clayton PT. Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6. JIMD Rep. 2016; 27:79-84. doi: 10.1007/8904_2015_460. [DOI:10.1007/8904_2015_460]
12. Ohtahara S, Yamatogi Y, Ohtsuka Y. Vitamin B(6) treatment of intractable seizures. Brain Dev. 2011; 33(9):783-9. doi: 10.1016/j.braindev.2011.01.010. [DOI:10.1016/j.braindev.2011.01.010]
13. Dreischmeier E, Zuloaga A, Kotloski RJ, Karasov AO, Gidal BE. Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy. Epilepsy Behav Rep. 2021; 16:100452. doi: 10.1016/j.ebr.2021.100452. [DOI:10.1016/j.ebr.2021.100452]
14. Yarlagadda A, Clayton AH. Blood brain barrier: the role of pyridoxine. Psychiatry (Edgmont) 2007; 4(8): 58‐60.
15. Nan Y, Lin J, Cui Y, Yao J, Yang Y, Li Q. Protective role of vitamin B6 against mitochondria damage in Drosophila models of SCA3. Neurochem Int. 2021;144:104979. doi: 10.1016/j.neuint.2021.104979. [DOI:10.1016/j.neuint.2021.104979]
16. Wang ZB, Gan Q, Rupert RL, Zeng YM, Song XJ. Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury. Pain 2005; 114(1-2): 266-77. doi: 10.1016/j.pain.2004.12.027. [DOI:10.1016/j.pain.2004.12.027]
17. Tardy AL, Pouteau E, Marquez D, Yilmaz C, Scholey A. Vitamins and Minerals for Energy, Fatigue and Cognition: A Narrative Review of the Biochemical and Clinical Evidence. Nutrients. 2020;12(1):228. doi: 10.3390/nu12010228. [DOI:10.3390/nu12010228]
18. Du X, Yang Y, Zhan X, Huang Y, Fu Y, Zhang Z, Liu H, Zhang L, Li Y, Wen Q, Zhou X, Zuo D, Zhou C, Li L, Hu S, Ma L. Vitamin B6 prevents excessive inflammation by reducing accumulation of sphingosine-1-phosphate in a sphingosine-1-phosphate lyase-dependent manner. J Cell Mol Med. 2020;24(22):13129-13138. doi: 10.1111/jcmm.15917. [DOI:10.1111/jcmm.15917]
19. Kuypers NJ, Hoane MR. Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat. J Neurotrauma 2010; 27(7):1275-82. doi: 10.1089/neu.2010.1327. [DOI:10.1089/neu.2010.1327]
20. Xiang C, Li ZN, Huang TZ, Li JH, Yang L, Wei JK. Threshold for maximal electroshock seizures (MEST) at three developmental stages in young mice. Zool Res 2019; 40(3): 231-235. doi: 10.24272/j.issn.2095-8137.2019.038. [DOI:10.24272/j.issn.2095-8137.2019.038]
21. Huizenga MN, Sepulveda-Rodriguez A, Forcelli PA. Preclinical safety and efficacy of cannabidivarin for early life seizures. Neuropharmacology 2019; 148: 189-198. doi: 10.1016/j.neuropharm.2019.01.002. [DOI:10.1016/j.neuropharm.2019.01.002]
22. Devi PU, Manocha A, Vohora D. Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers. Expert Opin Pharmacother 2008; 9(18): 3169-3177. doi:10.1517/14656560802568230. [DOI:10.1517/14656560802568230]
23. Pottoo FH, Salahuddin M, Khan FA, Al Dhamen MA, Alsaeed WJ, Gomaa MS, Vatte C, Alomary MN. Combinatorial regimen of carbamazepine and imipramine exhibits synergism against grandmal epilepsy in rats: inhibition of pro-inflammatory cytokines and pi3k/akt/mtor signaling pathway. Pharmaceuticals (Basel). 2021;14(11):1204. doi: 10.3390/ph14111204. [DOI:10.3390/ph14111204]
24. Twele F, Töllner K, Bankstahl M, Löscher W. The effects of carbamazepine in the intrahippocampal kainate model of temporal lobe epilepsy depend on seizure definition and mouse strain. Epilepsia Open 2016; 1(1-2): 45-60. doi: 10.1002/epi4.2. [DOI:10.1002/epi4.2]
25. Reeta KH, Mehla J, Pahuja M, Gupta YK. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Pharmacol Biochem Behav 2011; 99(3): 399-407. doi: 10.1016/j.pbb.2011.05.011. [DOI:10.1016/j.pbb.2011.05.011]
26. Abdou HM, Wahby MM. Neuroprotection of Grape Seed Extract and Pyridoxine against Triton-Induced Neurotoxicity. Oxid Med Cell Longev 2016; 2016: 8679506. doi:10.1155/2016/8679506. [DOI:10.1155/2016/8679506]
27. Sardari S, Amiri M, Rahimi H, Kamalinejad M, Narenjkar J, Sayyah M. Anticonvulsant effect of Cicer arietinum seed in animal models of epilepsy: introduction of an active molecule with novel chemical structure. Iran Biomed J. 2015; 19(1): 45-50. doi: 10.6091/ibj.1391.2014.
28. Golden N, Darmadipura S, Bagiada N A. The difference in seizure incidences between young and adult rats related to lipid peroxidation after intracortical injection of ferric chloride. Singapore Med J. 2010; 51(2): 105.
29. Gómez CD, Buijs RM, Sitges M. The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1β and TNF-α expression in rat hippocampus. J Neurochem. 2014;130(6):770-9. doi: 10.1111/jnc.12784. [DOI:10.1111/jnc.12784]
30. Dönmezdil N, Çevik MU, Özdemir HH, Taşin M. Investigation of PON1 activity and MDA levels in patients with epilepsy not receiving antiepileptic treatment. Neuropsychiatr Dis Treat. 2016;12:1013-7. doi: 10.2147/NDT.S103336. [DOI:10.2147/NDT.S103336]
31. Shehta, N., Kamel, A.E., Sobhy, E. et al. Malondialdehyde and superoxide dismutase levels in patients with epilepsy: a case-control study. Egypt J Neurol Psychiatry Neurosurg. 2022; 58:51. doi:10.1186/s41983-022-00479-5 [DOI:10.1186/s41983-022-00479-5]
32. Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F. Carbamazepine exerts anti-inflammatory effects in the rat. Eur J Pharmacol. 1995;294(1):71-4. doi: 10.1016/0014-2999(95)00516-1. [DOI:10.1016/0014-2999(95)00516-1]
33. Ehmedah A, Nedeljkovic P, Dacic S, Repac J, DraskovicPavlovic B, Vucevic D, et al. Vitamin B Complex Treatment Attenuates Local Inflammation after Peripheral Nerve Injury. Molecules 2019; 24(24): 4615. doi: 10.3390/molecules24244615. [DOI:10.3390/molecules24244615]
34. Czapiński P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem. 2005;5(1):3-14. doi: 10.2174/1568026053386962. [DOI:10.2174/1568026053386962]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
